Effects of Atorvastatin on peripheral blood monocytes in patients with HIV associated neurological disorders.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 20 Jan 2017
At a glance
- Drugs Atorvastatin (Primary)
- Indications Dementia; Neurological disorders
- Focus Biomarker; Pharmacodynamics; Pharmacogenomic
- Acronyms HAND
- 07 Jun 2017 Biomarkers information updated
- 13 Jan 2017 Planned End Date changed from 1 Oct 2016 to 1 Oct 2017.
- 13 Jan 2017 Planned primary completion date changed from 1 Oct 2016 to 1 Oct 2017.